Citations

Clear

4801 citation(s) found for "Yu, Jennifer".

Assessing Patients and Care Partner Ratings of Communication-Related Participation Restrictions: Insights From Degenerative Disease
Utianski, Rene L. , Martin, Peter R. , Duffy, Joseph R. , Clark, Heather M. , Stierwalt, Julie A. G., Botha, Hugo , Ali, Farwa , Whitwell, Jennifer L. , Josephs, Keith A. , Utianski, Rene L , Botha, Hugo , Clark, Heather M , Duffy, Joseph R , Whitwell, Jennifer L.

Mayo Clinic

American Journal of Speech-Language Pathology | February 9, 2023 | Volume: 32 | Issue: 4S | Pages: 1793-1805

10.1044/2022_ajslp-22-00140 | PMID 36758199 Get It

Purpose: Prior studies have shown that communication-related participation restrictions in patients with degenerative disease do not always match clinician judgment or objective indices of symptom severity. Although there is a growing body of literature documenting that discrepancies between patients with dementia and their care partners' perception of participation restrictions exist, it is not known how care partner perceptions of communication participation restrictions specifically match or diverge from the patients' experiences, which may inform the use of care partner proxy in the context of degenerative diseases. Method: Thirty-eight patients with progressive neurologic conditions (progressive supranuclear palsy, corticobasal syndrome, and primary progressive aphasia or apraxia of speech) and, in most instances, focal cognitive-communication disorders were included. The patients and their accompanying care partners independently completed the Communicative Participation Item Bank, short form, a 10-question survey about communication participation restrictions in different contexts. Care partners were instructed to complete the form with their perception of the patient's experience. The difference between patient and care partner total scores were calculated and analyzed relative to clinical and demographic variables of interest. Results: Care partner ratings modestly tracked with patient experience and objective indices of symptom severity but did not exactly match patient ratings. The presence of aphasia increased, but did not fully account for, the likelihood of a discrepancy between care partner and patient ratings. Conclusion: Although careful consideration should be given prior to using care-partner report as a proxy for patient experience, it is worthwhile to include care partner ratings as a means of supporting conversations about differing perceptions, guiding joint intervention planning, and monitoring care-partner perceptions of change along with the implementation of supported conversation strategies.
Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel
Taylor, Angela , Goldman, Jennifer G. , Poston, Kathleen L. , Goldman, Jennifer G , Sabbagh, Marwan Noel , Galasko, Douglas , Galvin, James E. , Leverenz, James B. , Boeve, Bradley F. , Irwin, David J. , Quinn, Joseph F.

Mayo Clinic

Alzheimer's & Dementia: Translational Research & Clinical Interventions | February 9, 2023 | Volume: 9 | Issue: 1 | Pages: No page available

10.1002/trc2.12375 | PMID 36873923 Get It

Abstract The regulatory path for drug approval is increasingly well defined. Drugs for the treatment of Alzheimer disease (AD) need to show statistically significant benefit over placebo with respect to cognitive and functional measures, with the Clinical Dementia Rating scale and Alzheimer's Disease Assessment Scale–Cognitive Subscale being among the most often used instruments in AD clinical trials. In contrast, there are no validated instruments for use in clinical trials of drugs for the treatment of dementia with Lewy bodies. This poses challenges for drug development because the regulatory pathway to drug approval requires demonstrable efficacy measures. In December 2021, the Lewy Body Dementia Association advisory group met with representatives from the US Food and Drug Administration to discuss the lack of approved drugs and treatments, discernment of efficacy measures, and identification of biomarkers. Highlights The Lewy Body with Dementia Association convened a listening session with the US Food and Drug Administration on dementia with Lewy bodies (DLB) and clinical trial design. Gaps include DLB‐specific measures, alpha synuclein biomarkers, and coexisting pathologies. DLB clinical trial design should focus on clinical value and disease specificity.
Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis
Horton, Mary , Shim, Joan E, Wallace, Amelia D. , Graves, Jennifer , Aaen, Gregory , Greenberg, Benjamin , Mar, Soe , Wheeler, Yolanda , Weinstock‐Guttman, Bianca , Schreiner, Teri , Tillema, Jan‐Mendelt , Casper, T. Charles , Hart, Janace, Quach, Hong , Quach, Diana , Schaefer, Catherine , Barcellos, Lisa F. , Horton, Mary K , Wallace, Amelia , Graves, Jennifer , Schreiner, Teri , Chitnis, Tanuja , Rensel, Mary R. , Weinstock‐Guttman, Bianca , Greenberg, Benjamin M , Shim, Joan E. , Waldman, Amy , Rodriguez, Moses , Krupp, Lauren , Waubant, Emmanuelle L.

Mayo Clinic

Multiple Sclerosis Journal | February 9, 2023 | Volume: 29 | Issue: 4-5 | Pages: 505-511

10.1177/13524585221150736 | PMID 36755464 Get It

Background: Rare genetic variants are emerging as important contributors to the heritability of multiple sclerosis (MS). Whether rare variants also contribute to pediatric-onset multiple sclerosis (POMS) is unknown. Objective: To test whether genes harboring rare variants associated with adult-onset MS risk ( PRF1, PRKRA, NLRP8 , and HDAC7 ) and 52 major histocompatibility complex (MHC) genes are associated with POMS. Methods: We analyzed DNA samples from 330 POMS cases and 306 controls from the US Network of Pediatric MS Centers and Kaiser Permanente Northern California for which Illumina ExomeChip genotypes were available. Using the gene-based method “SKAT-O,” we tested the association between candidate genes and POMS risk. Results: After correction for multiple comparisons, one adult-onset MS gene ( PRF1, p = 2.70 × 10 −3 ) and two MHC genes ( BRD2, p = 5.89 × 10 −5 and AGER, p = 7.96 × 10 −5 ) were significantly associated with POMS. Results suggest these are independent of HLA-DRB1*1501. Conclusion: Findings support a role for rare coding variants in POMS susceptibility. In particular, rare minor alleles within PRF1 were more common among individuals with POMS compared to controls while the opposite was true for rare variants within significant MHC genes, BRD2 and AGER . These genes would not have been identified by common variant studies, emphasizing the merits of investigating rare genetic variation in complex diseases.
Patient Outcomes and Unit Composition With Transition to a High-Intensity ICU Staffing Model: A Before-and-After Study
Proper, Jennifer , Shaker, Salma, Heisdorffer, Jamie, Shaker, Rami M. , Shiue, Larissa T., Pendleton, Kathryn M. , Siegel, Lianne , Reilkoff, Ronald A. , Wacker, David A. , Shaker, Salma

Mayo Clinic

Critical Care Explorations | February 8, 2023 | Volume: 5 | Issue: 2 | Pages: e0864

10.1097/cce.0000000000000864 | PMID 36778910 Get It

IMPORTANCE: Provider staffing models for ICUs are generally based on pragmatic necessities and historical norms at individual institutions. A better understanding of the role that provider staffing models play in determining patient outcomes and optimizing use of ICU resources is needed. OBJECTIVES: To explore the impact of transitioning from a low- to high-intensity intensivist staffing model on patient outcomes and unit composition. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective observational before-and-after study of adult ICU patients admitted to a single community hospital ICU before (October 2016–May 2017) and after (June 2017–November 2017) the transition to a high-intensity ICU staffing model. MAIN OUTCOMES AND MEASURES: The primary outcome was 30-day all-cause mortality. Secondary outcomes included in-hospital mortality, ICU length of stay (LOS), and unit composition characteristics including type (e.g., medical, surgical) and purpose (ICU-specific intervention vs close monitoring only) of admission. RESULTS: For the primary outcome, 1,219 subjects were included (779 low-intensity, 440 high-intensity). In multivariable analysis, the transition to a high-intensity staffing model was not associated with a decrease in 30-day (odds ratio [OR], 0.90; 95% CI, 0.61–1.34; p = 0.62) or in-hospital (OR, 0.89; 95% CI, 0.57–1.38; p = 0.60) mortality, nor ICU LOS. However, the proportion of patients admitted to the ICU without an ICU-specific need did decrease under the high-intensity staffing model (27.2% low-intensity to 17.5% high-intensity; p < 0.001). CONCLUSIONS AND RELEVANCE: Multivariable analysis showed no association between transition to a high-intensity ICU staffing model and mortality or LOS outcomes; however, the proportion of patients admitted without an ICU-specific need decreased under the high-intensity model. Further research is needed to determine whether a high-intensity staffing model may lead to more efficient ICU bed usage.
Baseline characteristics of the North American prodromal Synucleinopathy cohort
Lim, Miranda M. , Keil, Allison , Postuma, Ronald B. , Pelletier, Amélie , Gagnon, Jean‐François , Louis, Erik K. St. , Forsberg, Leah K. , Fields, Julie A. , Huddleston, Daniel E. , Howell, Michael J. , McLeland, Jennifer , Criswell, Susan R. , Miglis, Mitchell G. , Lee‐Iannotti, Joyce , Ju, Yo‐El S. , Summers, Rebekah L. S. , Ligman, Brittany R. , MacKinnon, Colum D. , Elliott, Jonathan E , Lim, Miranda M , Keil, Allison T , Postuma, Ronald B , Gagnon, Jean-François , St Louis, E K , Fields, Julie A , Huddleston, Daniel E , Bliwise, Donald L , Howell, Michael J , Criswell, Susan R , During, Emmanuel , Miglis, Mitchell G , Shprecher, David , Lee-Iannotti, Joyce K , Boeve, Brad , Ju, Yo-El S , Elliott, Jonathan E. , Bliwise, Donald L. , Avidan, Alon Y. , Schenck, Carlos H. , Videnovic, Aleksandar , Shprecher, David , Boeve, Bradley F.

Mayo Clinic

Annals of Clinical and Translational Neurology | February 8, 2023 | Volume: 10 | Issue: 4 | Pages: 520-535

10.1002/acn3.51738 | PMID 36751940 Get It

Abstract Objective Rapid eye movement (REM) sleep behavior disorder (RBD) is widely considered a prodromal synucleinopathy, as most with RBD develop overt synucleinopathy within ~10 years. Accordingly, RBD offers an opportunity to test potential treatments at the earliest stages of synucleinopathy. The North American Prodromal Synucleinopathy (NAPS) Consortium has created a multisite RBD participant, primarily clinic‐based cohort to better understand characteristics at diagnosis, and in future work, identify predictors of phenoconversion, develop synucleinopathy biomarkers, and enable early stage clinical trial enrollment. Methods Participants ≥18 years of age with overnight polysomnogram‐confirmed RBD without Parkinson's disease, dementia, multiple system atrophy, or narcolepsy were enrolled from nine sites across North America (8/2018 to 4/2021). Data collection included family/personal history of RBD and standardized assessments of cognitive, motor, sensory, and autonomic function. Results Outcomes are primarily reported based on sex (361 total: n = 295 male, n = 66 female), and secondarily based on history of antidepressant use ( n = 200 with, n = 154 without; with correction for sex differences) and based on extent of synucleinopathy burden ( n = 56 defined as isolated RBD, n = 305 defined as RBD+ [i.e., exhibiting ≥1 abnormality]). Overall, these participants commonly demonstrated abnormalities in global cognition (MoCA; 38%), motor function (alternate tap test; 48%), sensory (BSIT; 57%), autonomic function (orthostatic hypotension, 38.8%), and anxiety/depression (BAI and PHQ‐9; 39.3% and 31%, respectively). Interpretation These RBD participants, assessed with extensive history, demographic, cognitive, motor, sensory, and autonomic function demonstrated a lack of sex differences and high frequency of concomitant neurological abnormalities. These participants will be valuable for future longitudinal study and neuroprotective clinical trials.
Atomic Force Microscopy Micro-Indentation Methods for Determining the Elastic Modulus of Murine Articular Cartilage
Arnold, Katherine M. , Sicard, Delphine , Tschumperlin, Daniel J. , Westendorf, Jennifer J. , Westendorf, Jennifer J

Mayo Clinic

Sensors | February 7, 2023 | Volume: 23 | Issue: 4 | Pages: 1835

10.3390/s23041835 | PMID 36850434 Get It

The mechanical properties of biological tissues influence their function and can predict degenerative conditions before gross histological or physiological changes are detectable. This is especially true for structural tissues such as articular cartilage, which has a primarily mechanical function that declines after injury and in the early stages of osteoarthritis. While atomic force microscopy (AFM) has been used to test the elastic modulus of articular cartilage before, there is no agreement or consistency in methodologies reported. For murine articular cartilage, methods differ in two major ways: experimental parameter selection and sample preparation. Experimental parameters that affect AFM results include indentation force and cantilever stiffness; these are dependent on the tip, sample, and instrument used. The aim of this project was to optimize these experimental parameters to measure murine articular cartilage elastic modulus by AFM micro-indentation. We first investigated the effects of experimental parameters on a control material, polydimethylsiloxane gel (PDMS), which has an elastic modulus on the same order of magnitude as articular cartilage. Experimental parameters were narrowed on this control material, and then finalized on wildtype C57BL/6J murine articular cartilage samples that were prepared with a novel technique that allows for cryosectioning of epiphyseal segments of articular cartilage and long bones without decalcification. This technique facilitates precise localization of AFM measurements on the murine articular cartilage matrix and eliminates the need to separate cartilage from underlying bone tissues, which can be challenging in murine bones because of their small size. Together, the new sample preparation method and optimized experimental parameters provide a reliable standard operating procedure to measure microscale variations in the elastic modulus of murine articular cartilage.
Older black race is a risk factor for metabolic syndrome in cutaneous lupus erythematosus
Chen, Henry W. , Coias, Jennifer , Raman, Justin , Adams‐Huet, Beverley , Neeland, Ian J. , Chong, Benjamin F. , Coias, Jennifer L, Chong, Benjamin F

Mayo Clinic

Lupus | February 6, 2023 | Volume: 32 | Issue: 4 | Pages: 580-582

10.1177/09612033231154785 | PMID 36744807 Get It

Physiological Demands of a Self-Paced Firefighter Air-Management Course and Determination of Work Efficiency
Jagim, Andrew R. , Luedke, Joel, Dobbs, Ward C. , Markert, Adam, Zapp, Annette , Askow, Andrew T. , Kesler, Richard M. , Fields, Jennifer B. , Jones, Margaret T. , Erickson, Jacob L. , Luedke, Joel A, Askow, Andrew T , Jones, Margaret T , Jagim, Andrew R , Almonroeder, Thomas Gus

Mayo Clinic

Journal of Functional Morphology and Kinesiology | February 6, 2023 | Volume: 8 | Issue: 1 | Pages: 21

10.3390/jfmk8010021 | PMID 36810505 Get It

Firefighters often complete air management courses (AMC) to assess the ability to tolerate personal protective equipment, appropriately manage the breathing system and assess occupational performance. Little information is known relative to the physiological demands of AMCs, nor how to assess work efficiency in order to characterize occupational performance and evaluate progress. Purpose: To assess the physiological demands of an AMC and examine differences across BMI categories. A secondary aim was to develop an equation to assess work efficiency in firefighters. Methods: Fifty-seven firefighters (Women, n = 4; age: 37.2 ± 8.4 yr.; height: 182.0 ± 6.9 cm; body mass: 90.8 ± 13.1 kg; BMI: 27.8 ± 3.6 kg·m−2) completed an AMC per routine evaluation while wearing a department issued self-contained breathing apparatus and full protective gear. Course completion time, starting pounds per square inch (PSI) on the air cylinder, changes in PSI, and distance traveled were recorded. All firefighters were equipped with a wearable sensor integrated with a triaxial accelerometer and telemetry to assess movement kinematics, heart rate, energy expenditure, and training impulse. The AMC consisted of an initial section involving a hose line advance, rescue (body drag), stair climb, ladder raise, and forcible entry. This section was followed by a repeating loop, which consisted of a stair climb, search, hoist, and recovery walk. Firefighters repeated the course loop until the self-contained breathing apparatus air supply pressure reached 200 PSI, at which time they were instructed to lay down until the PSI reached zero. Results: Average completion time was 22.8 ± 1.4 min, with a mean distance of 1.4 ± 0.3 km and an average velocity of 2.4 ± 1.2 m·s−1. Throughout the AMC, the mean heart rate was 158.7 ± 11.5 bpm equating to 86.8 ± 6.3% of the age-predicted max heart rate and a training impulse of 55 ± 3 AU. Mean energy expenditure was 464 ± 86 kcals and work efficiency was 49.8 ± 14.9 km·PSI−1·s. Regression analysis determined that fat-free mass index (R2 = 0.315; β = −5.069), body fat percentage (R2 = 0.139; β = −0.853), fat-free mass (R2 = 0.176; β = −0.744), weight (R2 = 0.329; β = −0.681), and age (R2 = 0.096; β = −0.571) were significant predictors of work efficiency. Conclusions: The AMC is a highly aerobic task with near-maximal heart rates reached throughout the course. Smaller and leaner individuals achieved a higher degree of work efficiency during the AMC.
Medical physics practice guideline 4.b: Development, implementation, use and maintenance of safety checklists
Conroy, Leigh , Faught, Jacqueline, Bowers, Erika, Ecclestone, Gillian, Santos, Luis E. Fong de los, Hsu, Annie , Johnson, Jennifer Lynn, Kim, Grace Gwe‐Ya, Schechter, Naomi R., Schubert, Leah , Sterling, David A. , Fong de Los Santos, Luis E, Sterling, David A.

Mayo Clinic

Journal of Applied Clinical Medical Physics | February 5, 2023 | Volume: 24 | Issue: 3 | Pages: No page available

10.1002/acm2.13895 | PMID 36739483 Get It

AbstractThe American Association of Physicists in Medicine (AAPM) is a nonprofit professional society whose primary purposes are to advance the science, education, and professional practice of medical physics. The AAPM has more than 8000 members and is the principal organization of medical physicists in the US. The AAPM will periodically define new practice guidelines for medical physics practice to help advance the science of medical physics and to improve the quality of service to patients throughout the US. Existing medical physics practice guidelines will be reviewed for the purpose of revision or renewal, as appropriate, on their fifth anniversary or sooner. Each medical physics practice guideline represents a policy statement by the AAPM, has undergone a thorough consensus process in which it has been subjected to extensive review, and requires the approval of the Professional Council. The medical physics practice guidelines recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guidelines and technical standards by those entities not providing these services is not authorized. The following terms are used in the AAPM practice guidelines: Must and must not: Used to indicate that adherence to the recommendation is considered necessary to conform to this practice guideline. While must is the term to be used in the guidelines, if an entity that adopts the guideline has shall as the preferred term, the AAPM considers that must and shall have the same meaning. Should and should not: Used to indicate a prudent practice to which exceptions may occasionally be made in appropriate circumstances.